Clinical Trials
Enrolling Trials
11-20 of 151
A Phase 3, Randomized, Double-blind,Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])
Trinh, Thu-Thao T
Neurology - Other
Child
The primary objective of this study is to evaluate the effect of erenumab compared with placebo on the change in monthly migraine days from baseline to week 9 through week 12 of the double-blind treatment phase.
Florence, Hope
(715) 221-7255
Johnson, Megan A
(715) 389-4878
Leigh, Maricia
(715) 221-7275
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
Onitilo, Adedayo A
Lung - Lung
Adult
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells
Hurley, Alexa A
(715) 393-1019
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients With Advanced Melanoma (PET-Stop)
Gokalp Yasar, Demet
Melanoma
Adult
This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma that cannot be removed by surgery (unresectable). Anti-PD-1 therapy has become a standard therapy option for patients with unresectable melanoma. This trial is being done to determine if doctors can safely shorten the use of standard of care anti-PD1 therapy for melanoma by using biomarkers seen on PET/CT imaging and tumor biopsy.
Craig, Chani L
(715) 358-1838
Chippewa Center
2655 CTY HWY I
CHIPPEWA FALLS, WI 54729
Ladysmith Center
906 College Ave W
Ladysmith, WI 54848
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Wausau Center
2727 PLAZA DRIVE
WAUSAU, WI 54401
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
Wisconsin Rapids Center
220 24TH ST SOUTH
WISCONSIN RAPIDS, WI 54494
A Phase II, Observer-blind, Randomized, Controlled Study
to Evaluate the Immunogenicity and Safety of a Varicella
Vaccine at Various Potencies Compared With Varivax, as a
First Dose, Administered in Healthy Children in Their
Second Year of Life
Pulvermacher, Keith W
Infectious Disease
Child
The purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.
Florence, Hope
(715) 221-7255
Freeman, Sandra K
(715) 387-9059
Gault, Tammy
(715) 387-5673
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
A Phase II/III Trial of MEDI4736 (Durvalumab) and
Chemotherapy for Patients With High Grade Upper Tract
Urothelial Cancer Prior to Nephroureterectomy
Fagbemi, Seth O
Urology - Renal
Adult
This phase III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Tesmer, Brooke
(715) 221-7330
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma
Sharma, Rohit
Skin
Adult
This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Diagnostic & Treatment Center
3401 CRANBERRY BLVD
WESTON, WI 54476
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Fagbemi, Seth O
Rare Tumors - Pancreas
Adult
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Adam, Iddrisu
(715) 389-4041
Diagnostic & Treatment Center
3401 CRANBERRY BLVD
WESTON, WI 54476
Eau Claire Center
2116 Craig Rd
Eau Claire, WI 54701
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients With Borderline Performance Status
Lee, David
Lung - Lung
Adult
This trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hyperfractionated radiation therapy delivers smaller doses of radiation therapy over time and may kill more tumor cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
Craig, Chani L
(715) 358-1838
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Fagbemi, Seth O
Germ Cell Tumors - Germ Cell
Adult
To estimate the positive predictive value within each of the early stage testicular seminoma and nonseminoma groups using plasma miRNA 371 expression at relapse to detect germ cell malignancy.
Craig, Chani L
(715) 358-1838
Chippewa Center
2655 CTY HWY I
CHIPPEWA FALLS, WI 54729
Ladysmith Center
906 College Ave W
Ladysmith, WI 54848
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Wausau Center
2727 PLAZA DRIVE
WAUSAU, WI 54401
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476
Wisconsin Rapids Center
220 24TH ST SOUTH
WISCONSIN RAPIDS, WI 54494
A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Abboud Leon, Chady
Melanoma
Adult
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Adam, Iddrisu
(715) 389-4041
Marshfield Clinic Cancer Center - Eau Claire
2200 Craig Road
Eau Claire, WI 54701
Marshfield Medical Center - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
Minocqua Center
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Stevens Point Center
,
Weston Center
3501 CRANBERRY BLVD
WESTON, WI 54476